Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases (Q34207556)

31 July 2017

1 reference

title

Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases (English)

1 reference

31 July 2017

1 reference

1

Gerli R

1 reference

ORCID Public Data File 2021

31 July 2017

1 reference

author name string

Lunardi C

2

1 reference

31 July 2017

Vinante F

3

1 reference

31 July 2017

Bistoni O

4

1 reference

31 July 2017

Pizzolo G

5

1 reference

31 July 2017

Pitzalis C

6

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

72-77

1 reference

In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

1 reference

7 January 2021

CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Soluble CD30 antigen in human colostrum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Local expansion of allergen-specific CD30+Th2-type gamma delta T cells in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Allergen-induced CD30 expression on T cells of atopic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

CD30, Th2 cytokines and HIV infection: a complex and fascinating link

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Th1/Th2 cytokine balance in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

T cell immunoregulation in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Are T cells in rheumatoid synovium aggressors or bystanders?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Changes in the Th1 or Th2 cytokine dominance in the synovium of rheumatoid arthritis (RA): a kinetic study of the Th subsets in one unusual RA patient

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokine profile data

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

The biology of Stat4 and Stat6

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

High level of interleukin-10 production by the activated t cell population within the rheumatoid synovial membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Elevated interleukin-10 levels in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Murine models for systemic lupus erythematosus and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokines in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokine profile in the liver of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Significance of CD30-positive lymphocytes in livers in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Cytokines in autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Peripheral blood and intrathyroidal T cell clones from patients with thyroid autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

The pattern of a T(H)1 cytokine in autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901829-9

7 January 2021

10.1016/S1471-4906(00)01829-9

Identifiers

DOI

1 reference

31 July 2017

1 reference